@Adam7477882377 Avatar @Adam7477882377 Adam

Adam posts on X about $ocul, money, strong, arm the most. They currently have [--] followers and [--] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [--] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 27.08% stocks 16.67% technology brands 12.5% social networks 4.17% countries 2.08% currencies 2.08% cryptocurrencies 2.08%

Social topic influence $ocul #19, money 10.42%, strong 4.17%, arm 4.17%, stocks 4.17%, math 4.17%, $mltx 4.17%, linkedin #577, longterm 4.17%, ondo 4.17%

Top accounts mentioned or mentioned by @jeremyfalmouth @descartesidea @clinmean @zipjet @razbiotech @elmonogran42994 @houndcl @thefullanalysis @biotechobserver @lucasmichalek @patientman16079 @zeekinvests @ascendingbio @marcperiu @podcasthorse @meobserver @artofsubcarpath @voltinocro @flankes838811 @marekma88061202

Top assets mentioned Ocular Therapeutix, Inc. (OCUL) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Ondo (ONDO) Sanofi (SNY) IO Biotech, Inc. (IOBT) SuperRare (RARE) Kymera Therapeutics, Inc. (KYMR)

Top Social Posts

Top posts by engagements in the last [--] hours

"$ocul pump and dump event again"
X Link 2026-02-05T15:11Z [--] followers, [---] engagements

"$ocul longs when they will see strong control arm"
X Link 2026-02-14T16:16Z [--] followers, [----] engagements

"@zeekinvests $ocul really On that results sanofi decided to buy this stock for [--] bln $ U still believe that On sept they didn't have phase results so what's going on Imo there were no buyout offer"
X Link 2026-02-05T11:59Z [--] followers, [---] engagements

"@AscendingBio @ElMonoGran42994 Ur wrong el mono and im sure u are not biotech investors many stocks are waiting with their topline data to publish on bio confference often they announce it months before $ocul is late with that so the only chance is late-breaking"
X Link 2026-02-08T01:04Z [--] followers, [---] engagements

"@clinmean @JeremyFalmouth @zipjet @RazBioTech They are $ocul fanboys. They see only success believe on buyout rumours and thinks its easy money even that insider are sellin"
X Link 2026-02-10T14:12Z [--] followers, [---] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech The [----] mg dose of OTXTKI seems quite small compared to Clearside Biomedicals [--] mg although I understand they differ in the route of administration. This is just my opinion. (2/2) ROUTE OF ADMINISTRATION WHEN I SAID THERE IS NO DIFF"
X Link 2026-02-10T16:55Z [--] followers, [--] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech To be clear I do think $OCUL phase [--] results will likely be positive. My concern is that they may not live up to the very high expectations currently priced in especially given there was no full public phase [--] dataset and the phase [--] design differs meaningfully from phase 1"
X Link 2026-02-10T21:16Z [--] followers, [---] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech What stands out to me is the risk/reward math many bulls seem to assume: risking about $5 of downside to potentially gain $1020 upside and treating that asymmetry as highly probable. Markets rarely hand out easy edges like that without hidden uncertainty"
X Link 2026-02-10T21:16Z [--] followers, [--] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech Either expectations are stretched or the true probability of a clean market-pleasing outcome is lower than people assume. Math doesnt lie valuation and probability eventually have to reconcile"
X Link 2026-02-10T21:16Z [--] followers, [--] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech That's why i said about $mltx similar case. Rumours buyout everybody sure IT will work and what Huuge sad drug will be approved prob but won't generate money as people hoped"
X Link 2026-02-10T21:30Z [--] followers, [---] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech I get the durability argument six months would be competitive. But $OCULs pivotal readout isnt just a 6-month story. The primary endpoint is around [--] months with follow-up to [--] so sustained performance over that window is what really matters"
X Link 2026-02-10T21:41Z [--] followers, [---] engagements

"@DescartesIdea @JeremyFalmouth @clinmean @zipjet @RazBioTech And will it be better than eyepoint which had good phase [--] results ending phase [--] and discounted by 30% to $ocul"
X Link 2026-02-10T21:41Z [--] followers, [---] engagements

"To help people understand it link: https://www.ocutx.com/careers/open-positions/ https://www.ocutx.com/careers/open-positions/"
X Link 2026-02-15T11:59Z [--] followers, [---] engagements

"@clinmean Good post i am excited waiting for $ocul results i also think control arm will have good results"
X Link 2026-02-15T18:59Z [--] followers, [---] engagements

"@JeremyFalmouth Statistical significance isnt the same as clinical conviction. If the delta is under 20% it may pass on paper yet feel underwhelming for real adoption.Without a loading phase doctors will want a strong signal that durability doesnt sacrifice control specially in crowded amd"
X Link 2026-02-14T17:17Z [--] followers, [---] engagements

"@JeremyFalmouth Not financial advice just opinion ofc"
X Link 2026-02-14T17:19Z [--] followers, [--] engagements

"@ElMonoGran42994 On linkedin but on website carrer was one and on linkedin could be reroll i dont know english name of it but on website was only one as a "new""
X Link 2026-02-15T23:23Z [--] followers, [--] engagements

"In my view if $OCUL doesnt announce next week that it plans to present data at the macula thats a very bad omen. That's just my opinion"
X Link 2026-02-13T19:10Z [--] followers, [---] engagements

"@houndcl @JeremyFalmouth So what's the sense of this therapy with low delta and often loading phase when they can use one dose elyea per [--] month without loading Its without sense for me specially with busy amd market"
X Link 2026-02-14T17:36Z [--] followers, [---] engagements

"$ocul how lazy are people tellin its [--] new jobs cause linkedin when on their website carrer is [--] Jobs offer and only one has "new". New jobs ofc dont say anything about success many bio stocks showed that"
X Link 2026-02-15T11:58Z [--] followers, [---] engagements

"@TheFullAnalysis Pre announcing means nothing same as ur jobs. $iobt Last time ocul also pre announced phase [--] and what Stock down . People are comparing to crv but that time people were bearish and short was 17% before data if i remember good"
X Link 2026-02-15T18:45Z [--] followers, [---] engagements

"@BiotechObserver @clinmean Few people will but its sham injection and is sol is elyea so it can give [--] extra months without losing any letter to control arm"
X Link 2026-02-16T01:19Z [--] followers, [--] engagements

"@ElMonoGran42994 @Marc_periu [--] home run So why rbc capital told 100% and more upside if 50% delta"
X Link 2026-02-16T14:44Z [--] followers, [--] engagements

"@podcast_horse @ME_Observer_ Irans won't respond. They can only talk what they can do but it will never happen. Its sad"
X Link 2023-12-25T19:14Z [--] followers, [--] engagements

"@ArtOfSubcarpath Za duo longow jak wchodz na investing czy to polski czy angielski bd x to ju nikt nie jest w shortach a kady widzi [--] i wicej. Pogoda po [--] znowu ma si ociepli. Zobaczymy osobiscie myl e smart money grao od [---] longi i Tera bd wychodzi"
X Link 2024-01-07T10:52Z [--] followers, [--] engagements

"@voltino_cro I doubt. I think this bad weather is in price already. It is almost [--] percent up if you count rollover contract. Its gas:P better than casino"
X Link 2024-01-07T16:26Z [--] followers, [--] engagements

"@flankes838811 Kady mwia nie zaatakuj. Tak samo byo na Ukrainie a nastpnie kady powie : przecie byo tyle czytelnych znakw sami zapowiedzieli. obecnie testuj polski system antyrakietowy Szwecja mwi o wojnie Estonia chce zaminowa granic Tajwan z Chinami no nie ma znakw"
X Link 2024-01-14T21:41Z [--] followers, [--] engagements

"@MarekMa88061202 Dokadnie i dlatego robi apank Ukraicw z Polski eby ich wcieli do armii bo taka maj przewag a front przesuwa si w kierunku Ukrainy bo to zmyka pewnie no dlatego nie powinno by w UE ani NATO bo to niczym si nie rni od Rosji"
X Link 2024-02-26T20:52Z [--] followers, [--] engagements

"@Przemek74341280 @lucas_michalek On to typowy walek w reklamie mwi o longterm a chwali zysk na ondo czy innym syfie po [--] msc czyli longterm jak straty bo nie dopuszcza e go moe wyzerowa hah"
X Link 2024-05-08T19:23Z [--] followers, [--] engagements

"@Damian12796030 @lucas_michalek Chop zapomnia jak reklamuje na yt longterm i chwali si zyskami ondo po kilku miesicach czyli jest longterm gdy jest w stracie a zyski po [--] miesicach czyli na ju :)"
X Link 2024-06-09T09:31Z [--] followers, [--] engagements

"@bullenario @NewsoftheMarket @grok how much money does grab a gun get net"
X Link 2025-07-17T15:56Z [--] followers, [--] engagements

"$MREO @PatientMan16079 Whatsapp my best clown How about ur shorts"
X Link 2025-12-22T17:46Z [--] followers, [---] engagements

"@Nick66112 @Spcowins Typical biotecn investor xD same people were talking about how bad is $capr. He took 85% from his a*s"
X Link 2025-12-15T15:58Z [--] followers, [--] engagements

"@JeffNNNG I think that there are maybe some buyout talks. Stock is cheap $rare can buy IT"
X Link 2025-12-19T19:56Z [--] followers, [--] engagements

"@badinvestor99 What are u fkin talking about If not today mb [--] or [--] but first week od Jan"
X Link 2025-12-23T21:17Z [--] followers, [---] engagements

"@PatientMan16079 @Dball435 So u tellin $mreo wont workbut amgen yes same biology. Ooh what a clown"
X Link 2025-12-25T10:06Z [--] followers, [---] engagements

"@ApolloResearchC Go short more hahaha this should be 2b value with this results eating $nktr and $kymr"
X Link 2026-01-20T12:52Z [--] followers, [---] engagements

"@houndcl $ocul One thing I struggle with: Oculars implant is said to biodegrade over [--] months yet the Phase [--] study runs for [--] months. So what exactly supports efficacy in the last [--] months PK tail residual effect or rescue injections (1/2)"
X Link 2026-01-31T15:03Z [--] followers, [---] engagements

"@ForHRAge @avidresearch Long $ocul cause rumours about buyout or what reason Easy money"
X Link 2026-02-04T23:47Z [--] followers, [---] engagements

"$crdf squeeze the shorts 30%"
X Link 2025-07-29T20:15Z [--] followers, [--] engagements

"$fulc great data dose-related response"
X Link 2025-12-06T22:34Z [--] followers, [---] engagements

"$snti when are data"
X Link 2025-12-08T23:55Z [--] followers, [---] engagements

"$nktr from Red to green nice panic sellers listen more shorters dr"
X Link 2025-12-16T13:42Z [--] followers, [---] engagements

"20% short on $crvs you know what you should do guys"
X Link 2026-01-20T12:18Z [--] followers, [---] engagements

"$crvs fantastic data lets squeeze shorts"
X Link 2026-01-20T12:04Z [--] followers, [---] engagements

"Did $ocul publicate phase [--] results in wet amd and i just can't find it or people trust rumours about buyout xD"
X Link 2026-01-20T20:18Z [--] followers, [---] engagements

"The [----] mg dose of OTXTKI seems quite small compared to Clearside Biomedicals [--] mg although I understand they differ in the route of administration. This is just my opinion. (2/2)"
X Link 2026-01-30T21:22Z [--] followers, [---] engagements

"Could $OCUL be the next $MLTX There were also rumours about a buyout of $MLTX by Merck but $MLTX refusedand we all saw how the stock reacted after the data. I dont like this sell-off after the news especially since there is no public Phase [--] data yet. (1/2)"
X Link 2026-01-30T21:21Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing